本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kiniksa Pharmaceuticals Ltd.

80.00
+0.62000.78%
成交量:22.21萬
成交額:1,771.54萬
市值:62.42億
市盈率:80.81
高:80.07
開:79.36
低:79.22
收:79.38
52周最高:82.94
52周最低:32.89
股本:7,802.40萬
流通股本:4,019.47萬
量比:0.71
換手率:0.55%
股息:- -
股息率:- -
每股收益(TTM):0.9900
每股收益(LYR):0.7500
淨資產收益率:14.04%
總資產收益率:8.05%
市淨率:9.54
市盈率(LYR):106.67

資料載入中...

2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/30

超過5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/07/29

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/07/28

重要事件披露

Form 8-K - Current report
2026/05/29

重要事件披露

Form 8-K - Current report
2026/05/26

重要事件披露

Form 8-K - Current report
2026/05/06

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/05/01

重要事件披露

Form 8-K - Current report
2026/04/28

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/28

重要事件披露

Form 8-K - Current report
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/04/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities